These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33247799)

  • 21. Histological margin assessment for breast ductal carcinoma in situ: precision and implications.
    Sigal-Zafrani B; Lewis JS; Clough KB; Vincent-Salomon A; Fourquet A; Meunier M; Falcou MC; Sastre-Garau X;
    Mod Pathol; 2004 Jan; 17(1):81-8. PubMed ID: 14657957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of surgeon performed intraoperative specimen ink in breast conservation surgery.
    Van Den Bruele AB; Jasra B; Smotherman C; Crandall M; Samiian L
    J Surg Res; 2018 Nov; 231():441-447. PubMed ID: 30278966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Selective Image-Guided Intraoperative Margin Resection Improve Re-Excision Rates after Lumpectomy in Ductal Carcinoma
    Gray K; Ayabe R; Shover A; Moazzez A; Ozao-Choy J; Dauphine C
    Am Surg; 2018 Oct; 84(10):1580-1583. PubMed ID: 30747673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
    Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
    Ward ST; Jones BG; Jewkes AJ
    Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of consensus guidelines for breast-conserving surgery in patients with ductal carcinoma in situ.
    Tremelling A; Aft RL; Cyr AE; Gillanders WE; Glover-Collins K; Herrmann V; Margenthaler JA
    Cancer Rep (Hoboken); 2022 May; 5(5):e1502. PubMed ID: 34245135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
    Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
    Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.
    Cao D; Lin C; Woo SH; Vang R; Tsangaris TN; Argani P
    Am J Surg Pathol; 2005 Dec; 29(12):1625-32. PubMed ID: 16327435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What should be the width of radiological margin to optimize resection of non-palpable invasive or in situ ductal carcinoma?
    Ouldamer L; Lechaux E; Arbion F; Body G; Vildé A
    Breast; 2014 Dec; 23(6):889-93. PubMed ID: 25456102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Single institution's randomized double-armed prospective study of lumpectomy margins with adjunctive use of the MarginProbe in nonpalpable breast cancers.
    Geha RC; Taback B; Cadena L; Borden B; Feldman S
    Breast J; 2020 Nov; 26(11):2157-2162. PubMed ID: 32772474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of margin status in breast conservation surgery and its correlation with subsequent re-excision findings.
    Krishnamurthy K; Febres-Aldana CA; Alghamdi S; Mesko T; Paramo J; Poppiti RJ
    Pathologica; 2019 Mar; 111(1):31-36. PubMed ID: 31217620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual disease after re-excision lumpectomy for close margins.
    Sabel MS; Rogers K; Griffith K; Jagsi R; Kleer CG; Diehl KA; Breslin TM; Cimmino VM; Chang AE; Newman LA
    J Surg Oncol; 2009 Feb; 99(2):99-103. PubMed ID: 19065638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance characteristics of specimen radiography for margin assessment for ductal carcinoma in situ: a systematic review.
    Versteegden DPA; Keizer LGG; Schlooz-Vries MS; Duijm LEM; Wauters CAP; Strobbe LJA
    Breast Cancer Res Treat; 2017 Dec; 166(3):669-679. PubMed ID: 28831674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.
    Asioli S; Morandi L; Cavatorta C; Cucchi MC; Foschini MP
    Eur J Surg Oncol; 2016 Dec; 42(12):1806-1813. PubMed ID: 27546014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?
    Livingston-Rosanoff D; Trentham-Dietz A; Hampton JM; Newcomb PA; Wilke LG
    Breast Cancer Res Treat; 2021 Sep; 189(2):463-470. PubMed ID: 34129117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery.
    Racz JM; Glasgow AE; Keeney GL; Degnim AC; Hieken TJ; Jakub JW; Cheville JC; Habermann EB; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(13):5303-5311. PubMed ID: 32623609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.